Samantha Semenkow
Stock Analyst at Citigroup
(0.73)
# 2,881
Out of 4,479 analysts
33
Total ratings
17.39%
Success rate
-10.67%
Average return
Main Sectors:
Top Industries:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Reinstates: Buy | $4 | $0.60 | +572.27% | 2 | Jun 3, 2024 | |
| LRMR Larimar Therapeutics | Maintains: Buy | $10 → $14 | $8.24 | +69.90% | 6 | May 22, 2024 | |
| PRME Prime Medicine | Upgrades: Buy | $10 | $5.48 | +82.48% | 2 | May 16, 2024 | |
| EDIT Editas Medicine | Maintains: Buy | $16 → $15 | $4.61 | +225.38% | 4 | May 9, 2024 | |
| TSVT 2seventy bio | Maintains: Buy | $9 → $12 | $4.05 | +196.30% | 2 | Apr 8, 2024 | |
| CABA Cabaletta Bio | Maintains: Buy | $26 → $30 | $7.81 | +284.12% | 2 | Apr 4, 2024 | |
| CPRX Catalyst Pharmaceuticals | Initiates: Buy | $27 | $15.77 | +71.21% | 1 | Mar 14, 2024 | |
| SLRN Acelyrin | Initiates: Neutral | $8 | $4.24 | +88.68% | 1 | Dec 8, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Buy | $7 | $2.33 | +200.43% | 1 | Dec 8, 2023 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Buy | $72 | $41.80 | +72.25% | 1 | Dec 8, 2023 | |
| MORF Morphic Holding | Initiates: Buy | $46 | $32.55 | +41.32% | 1 | Dec 8, 2023 | |
| ARGX argenx SE | Maintains: Buy | $610 → $591 | $434.22 | +36.11% | 3 | Nov 29, 2023 | |
| IMVT Immunovant | Maintains: Buy | $33 → $50 | $27.51 | +81.75% | 3 | Sep 27, 2023 | |
| SANA Sana Biotechnology | Initiates: Buy | $8 | $5.47 | +46.25% | 1 | Sep 5, 2023 | |
| BEAM Beam Therapeutics | Maintains: Buy | $60 → $56 | $23.05 | +142.95% | 3 | Aug 9, 2023 |
Sensei Biotherapeutics
Jun 3, 2024
Reinstates: Buy
Price Target: $4
Current: $0.60
Upside: +572.27%
Larimar Therapeutics
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $8.24
Upside: +69.90%
Prime Medicine
May 16, 2024
Upgrades: Buy
Price Target: $10
Current: $5.48
Upside: +82.48%
Editas Medicine
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $4.61
Upside: +225.38%
2seventy bio
Apr 8, 2024
Maintains: Buy
Price Target: $9 → $12
Current: $4.05
Upside: +196.30%
Cabaletta Bio
Apr 4, 2024
Maintains: Buy
Price Target: $26 → $30
Current: $7.81
Upside: +284.12%
Catalyst Pharmaceuticals
Mar 14, 2024
Initiates: Buy
Price Target: $27
Current: $15.77
Upside: +71.21%
Acelyrin
Dec 8, 2023
Initiates: Neutral
Price Target: $8
Current: $4.24
Upside: +88.68%
Allogene Therapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $7
Current: $2.33
Upside: +200.43%
MoonLake Immunotherapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $41.80
Upside: +72.25%
Morphic Holding
Dec 8, 2023
Initiates: Buy
Price Target: $46
Current: $32.55
Upside: +41.32%
argenx SE
Nov 29, 2023
Maintains: Buy
Price Target: $610 → $591
Current: $434.22
Upside: +36.11%
Immunovant
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $27.51
Upside: +81.75%
Sana Biotechnology
Sep 5, 2023
Initiates: Buy
Price Target: $8
Current: $5.47
Upside: +46.25%
Beam Therapeutics
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $23.05
Upside: +142.95%